SPOKE Raises $6.7

Online Oceans

Online Oceans designs, builds and operates cutting-edge Ocean Robots.

Exaba

Exaba™ powers the world’s first LocalScaler data storage platform, designed specifically for MSPs. We deliver high-performance, ultra-resilient backup and data protection that runs where your customers need it. With control, transparency, and low-cost scalability at the core, our platform helps service providers build stronger margins, deeper trust, and modern data services that stand apart.

OneReg

OneReg is the only complete platform for aviation regulatory assurance. Trusted by leading aviation operators worldwide, OneReg was built specifically for the highly regulated needs of the aviation industry. We help airports and airlines run safer, smarter, more efficient operations. OneReg replaces multiple fragmented systems to manage regulatory complexity through the full lifecycle in one place: - Regulatory requirements - Documents, policies, and procedures - Operational execution - Monitoring and alerting - Occurrences and investigations - Evidence and traceability - Assurance and reporting - Contractor and third-party compliance Aviation teams choose OneReg for: - One source of truth - Certainty around compliance status - Digital transformation of daily operations - Modern technology built by aviation experts Learn more on our website or message us for a platform demo.

Pacific Edge Ltd

Pacific Edge Limited (NZX/ ASX: PEB) is a global cancer diagnostics company leading the way in the development and commercialization of bladder cancer diagnostic and prognostic tests for patients presenting with hematuria or surveillance of recurrent disease. Headquartered in Dunedin, New Zealand, the company provides its suite of Cxbladder tests globally through its wholly owned, and CLIA certified, laboratories in New Zealand and the USA. Cxbladder is a suite of non-invasive genomic urine tests optimized for the risk stratification of urothelial cancer in patients presenting with microhematuria and those being monitored for recurrent disease. The tests help improve the overall patient experience, while prioritizing time and clinical resources to optimize practice workflow and improve efficiency. Supported by over 20 years of research, Cxbladder’s evidence portfolio extends to more than 25 peer reviewed publications, and Cxbladder Triage is now included in the American Urological Association’s Microhematuria Guideline. To drive increased adoption and improved patient health outcomes, Cxbladder is the focal point of numerous ongoing and planned studies designed to generate further clinical utility evidence. Cxbladder is available in the US, Australasia, and Israel and in markets throughout Asia and South America. In the US, the test has been used by over 5,000 urologists who have ordered more than 130,000 tests. In New Zealand, Cxbladder is accessible to around 70% of the population via public healthcare and all residents have the option of buying the test online. Learn more at www.cxbladder.com

Halter

We’re on a mission to unlock more productive and sustainable agriculture. Farmers are using Halter to break free from the time-intensive constraints of conventional farming. They’re growing more grass, increasing milk production and improving the health and well-being of their cows. We bridge deep tech into real-world farming by enabling farmers to remotely shift, virtually fence and proactively monitor their cows’ health and behaviour. We’re backed to deliver on a mission that matters by Tier 1 investors including DCVC, Blackbird, Promus Ventures, Rocket Lab’s Peter Beck and Icehouse ventures. Halter's headquarters are in Auckland, New Zealand.